World Hepatitis Diagnostic Market Analyzed & Forecast in New VPG Study Published at MarketPublishers.сom
04 Sep 2012 • by Natalie Aster
LONDON – Viral hepatitis is a global health problem that affects hundreds of millions of children and adults. Although multiple pathogens have been associated with hepatitis, three in particular (Hepatitis A, B, and C) are responsible for the majority of virally-linked hepatitis cases. Chronic viral hepatitis B and C are a major cause of chronic liver disease which may manifest as liver fibrosis and cirrhosis leading to liver cancer and the need for liver transplantation.
New study “Future Horizons in the Global Hepatitis Diagnostic Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country” elaborated by Venture Planning Group (VPG) presents a detailed analysis of the hepatitis diagnostics market in the US, France, Germany, Italy, Spain, the UK and Japan. For each country, in addition to 5- and 10-year test volume and sales projections, the report presents sales and market share estimates for major suppliers of hepatitis tests.
Furthermore, the study examines the market applications of DNA probes, monoclonal antibodies, immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Future Horizons in the Global Hepatitis Diagnostic Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country
Published: August, 2012
Price: US$ 8.750,00
More new market research studies by the publisher can be found at VPG page.